What is the recommended tapering schedule for escitalopram (Lexapro) 5 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The recommended tapering schedule for escitalopram (Lexapro) 5 mg daily is to taper the dose hyperbolically and slowly to minimize withdrawal symptoms, as suggested by the most recent and highest quality study 1.

Tapering Schedule

To taper escitalopram 5 mg daily, it is essential to reduce the dose gradually to allow the brain to adjust to decreasing levels of serotonin.

  • The tapering schedule should be individualized, but a general approach is to reduce the dose by small increments every 2-4 weeks.
  • Since you're already on a low dose of 5 mg, you would typically reduce to 2.5 mg daily for 2-4 weeks, then stop completely.
  • If 2.5 mg tablets aren't available, you could take 5 mg every other day for 2-4 weeks before discontinuing.

Minimizing Withdrawal Symptoms

Withdrawal symptoms can include dizziness, nausea, headaches, irritability, anxiety, and sensory disturbances like "brain zaps."

  • The slow reduction allows your brain to adjust to decreasing levels of serotonin as the medication is withdrawn.
  • If you experience significant withdrawal symptoms during the taper, you may need to reduce the dose more slowly.

Importance of Consultation

Always consult with your healthcare provider before changing your medication regimen, as individual factors may require personalized adjustments to this general tapering schedule.

Key Considerations

  • The study 1 suggests that tapering SSRIs hyperbolically and slowly can minimize withdrawal symptoms.
  • Other studies 2, 3, 4, 5 provide information on the pharmacokinetics, efficacy, and tolerability of escitalopram, but the most recent and highest quality study 1 should be prioritized when determining the tapering schedule.

References

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Research

Escitalopram.

Expert opinion on investigational drugs, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.